Blood pressure in relation to obesity, insulin and the hypothalamic-pituitary-adrenal axis in Swedish men

Journal of Hypertension

Volumn 16, Issue 12, 1998, Pages 1721-1726

  Rosmond, Roland ^a   Björntorp, Per ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Body mass index; Diastolic blood pressure; Insulin resistance; Sagittal diameter; Systolic blood pressure; Waist:hip circumference ratio

Indexed keywords

GLUCOSE; HYDROCORTISONE; INSULIN;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; HYDROCORTISONE RELEASE; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; OBESITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE;

EID: 0031736959     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816120-00003     Document Type: Article

References (41)

1. Björntorp P. The associations between obesity, adipose tissue distribution and disease. Acta Med Scand 1987; 723:121-134.
2. Kannel WB, Brand N, Skinner JJ, Dawber TR, McNamara PM. The relation of adiposity to blood pressure and development of hypertension: the Framingham Study. Ann Intern Med 1967; 67:48-59.
3. Chiang BN, Perlman LV, Epstein FH. Overweight and hypertension: a review. Circulation 1969; 39:403-421.
4. Krotkiewski M, Björntorp P, Sjöström L, Smith U. Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest 1983; 72:1150-1162.
5. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev 1994; 74:761-811.
6. Dengel DR, Goldberg AP, Mayuga RS, Kairis GM, Weir MR. Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 1996; 28:127-132.
7. Reisin E, Messerli FG, Ventura HO, Frohlich ED. Renal haemodynamic studies in obesity hypertension. J Hypertens 1987; 5:397-400.
8. Defronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975; 55:845-855.
9. Krieger DR, Landsberg L. Mechanisms in obesity-related hypertension: role of insulin and catecholamines. Am J Hypertens 1988; 1:84-90.
10. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, et al. Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75:809-817.
11. Haffner SM, Miettinen H, Gaskill SP, Stern MP. Metabolic precursors of hypertension: the San Antonio Heart Study. Arch Intern Med 1996; 156:1994-2000.
12. Fagot-Campagna A, Balkau B, Simon D, Ducimetière P, Eschwège E. Is insulin an independent risk factor for hypertension? The Paris Prospective Study. Int J Epidemiol 1997; 26:542-550.
13. Lind L, Lithell H, Pollare T. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors? J Hypertens 1993; 11 (suppl 4):S11-S16.
14. Feskens EJM, Tuomilehto J, Stengård JH, Pekkanen J, Nissinen A, Kromhout D. Hypertension and overweight associated with hyperinsulinaemia and glucose tolerance: a longitudinal study of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetologia 1995; 38:839-847.
15. Hall JE, Brands MW, Zappe DH, Alonso Galicia M. Insulin resistance, hyperinsulinemia, and hypertension: causes, consequences, or merely correlations? Proc Soc Exp Biol Med 1995; 208:317-329.
16. Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett AR, et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Metabolism 1996; 45:699-706.
17. Rosmond R, Dallman MF, Björntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998; 83:1853-1859.
18. Després J-P. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 1993; 9:452-459.
19. Richard D. Involvement of corticotropin-releasing factor in the control of food intake and energy expenditure. Ann NY Acad Sci 1993; 697:155-172.
20. Rosmond R, Lapidus L, Björntorp P. The influence of occupational and social factors on obesity and body fat distribution in middle-aged men. Int J Obes Relat Metab Disord 1996; 20:599-607.
21. Rosmond R, Lapidus L, Mårin P, Björntorp P. Mental distress, obesity and body fat distribution in middle-aged men. Obes Res 1996; 4:245-252.
22. Kronmal RA, Rutan GH, Manolio TA, Borhani NO. Properties of the random zero sphygmomanometer. Hypertension 1993; 21:632-637.
23. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chronic Dis 1972; 25:329-343.
24. Pouliot M-C, Després J-P, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73:460-468.
25. Sjöström L, Lönn L, Chowdhury B, Grangård U, Lissner L, Sjöström D, et al. The sagittal diameter is a valid marker of the visceral adipose tissue volume. Progr Obes Res 1996; 7:309-319.
26. Römer M, Haeckel R, Bonini P, Ceriotti G, Vassault A, Solere P, et al. European multicentre evaluation of the ESAT 6660. J Clin Chem Clin Biochem 1990; 28:435-443.
27. Thompson B. Canonical correlation analysis: uses and interpretation. London: Sage Publications; 1984.
28. Sprent P. Applied nonparametric statistical methods. London: Chapman and Hall; 1993.
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
30. Kvist H, Chowdhury B, Grangård U, Tylén U, Sjöström L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 1988; 48:1351-1361.
31. Siervogel RM, Roche AF, Chumlea WC, Morris JG, Webb P, Knittle JL. Blood pressure, body composition, and fat tissue cellularity in adults. Hypertension 1982; 4:382-386.
32. Weinsier RL, Norris DJ, Birch R, Bernstein RS, Wang J, Yang M-U, et al. The relative contribution of body fat and fat pattern to blood pressure level. Hypertension 1985; 7:578-585.
33. Grugni G, Ardizzi A, Dubini A, Guzzaloni G, Sartorio A, Morabito F. No correlation between insulin levels and high blood pressure in obese subjects. Horm Metab Res 1990; 22:124-125.
34. O'Shaughnessy IM, Myers TJ, Stepniakowski K, Nazzaro P, Kelly TM, Hoffmann RG, et al. Glucose metabolism in abdominally obese hypertensive and normotensive subjects. Hypertension 1995; 26:186-192.
35. Zavaroni I, Mazza S, Dall'Anglio E, Gasparini P, Passeri M, Reaven GM. Prevalence of hyperinsulinaemia in patients with high blood pressure. J Intern Med 1992; 231:235-240.
36. Philips DIW, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med 1994; 11:286-292.
37. Björntorp P. The regulation of adipose tissue distribution in humans. Int J Obes Relat Metab Disord 1996; 20:291-302.
38. Dallman MF, Akana SF, Scribner KA, Bradbury MJ, Walker OM, Strack AM, et al. Stress, feedback and facilitation in the hypothalamo-pituitary-adrenal axis. J Neuroendocrinol 1992; 4:517-526.
39. Julius S, Esler MD, Randall OS. Role of the autonomic nervous system in mild human hypertension. Clin Sci Mol Med 1975; 48:243-252.
40. Folkow B. Stress, hypothalamic function and neuroendocrine consequences. Acta Med Scand 1987; 723:61-69.
41. Holmäng A, Jennische E, Björntorp P. The effects of long-term hyperinsulinaemia on insulin sensitivity in rats. Acta Physiol Scand 1995; 153:67-73.